Latest Hair Transplant & Hair Loss Topic

What is Androgenetic Alopecia?

Androgenetic alopecia is hair loss that occurs in male and females due to an underlying susceptibility of hair follicles to androgenetic miniaturization. Androgenic alopecia is the most common cause of hair loss and will affect up to 70% of men and 40% of women at some point in their lifetimes. Men typically start with hairline recession at the temples and balding at the crown, while women normally start to thin on their center part. Both genetic and environmental factors play a major role in androgenic alopecia.

As androgenetic alopecia progresses, a rim of hair at the sides and rear of the head will remain. Once this occurs it is referred to as a ‘Hippocratic wreath’, and does not normally progress to complete baldness.

Female androgenetic alopecia more often causes diffuse thinning without hairline recession; and, like its male counterpart, rarely leads to total hair loss.

Androgenetic Alopecia Treatment and Management

Only two drugs currently have US Food and Drug Administration (FDA)–approved indications for treatment of androgenic alopecia: minoxidil and finasteride.

Other types of management include Platelet Rich Plasma (PRP) and Hair Restoration surgery.